AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04176172 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment
Description: Standard behavioral smoking cessation treatment is an effective treatment for nicotine dependence. Treatment focuses on self-monitoring of smoking behavior, identifying smoking triggers and alternative trigger management strategies, relaxation, social support for non-smoking, and relapse prevention. Participants will receive up to 5 therapy sessions (2 in person, 3 over the phone) over 8 weeks.
Study NCT04176172 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard treatment + Managed Problem Solving (MAPS) adherence intervention
Description: Standard behavioral smoking cessation treatment is an effective treatment for nicotine dependence. Treatment focuses on self-monitoring of smoking behavior, identifying smoking triggers and alternative trigger management strategies, relaxation, social support for non-smoking, and relapse prevention. Managed Problem Solving (MAPS) is a therapeutic process that involves the systematic delineation of a participant's medication adherence problems and construction of a series of individualized solutions that therapists and participants explore together. Participants will receive up to 5 therapy sessions (2 in person, 3 over the phone) over 8 weeks. The first session will directly address potential medication adherence barriers, and therapist and participant will collaboratively brainstorm ways to overcome these barriers.
Study NCT01533974 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acceptance & Commitment Therapy (ACT)
Description: We will use a five-session (90 minutes per session) group-delivered adaptation of Dr. Bricker's ACT treatment program.
Study NCT01533974 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Description: The control condition will be the current group-delivered CBT smoking cessation program at GH.
Study NCT01939015 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3D titanium miniplate
Description: for study group by using 3D titanium miniplate under open reduction under general anesthesia with mono cortical screw, while in control group single titanium miniplate at superior border with mono cortical screw according to ideal line of osteosynthesis of champy
Study NCT00003199 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: May undergo radiotherapy after completion of IL-2/GM-CSF
Study NCT04627207 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-330 1 Tab. and D085 1 Tab.
Description: Other names: Reference
Study NCT01939015 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D titanium miniplate
Description: for study group by using 3D titanium miniplate under open reduction under general anesthesia with mono cortical screw, while in control group single titanium miniplate at superior border with mono cortical screw according to ideal line of osteosynthesis of champy
Study NCT01939015 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard titanium miniplate- single non compression miniplate
Description: single non compression miniplate placed at superior border with monocortical screws via intraoral approach
Study NCT01939015 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard titanium miniplate- single non compression miniplate
Description: single non compression miniplate placed at superior border with monocortical screws via intraoral approach
Study NCT02788981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone
Description: Patients will receive mifepristone 300 mg daily on the day prior to and day of each dose of nab-paclitaxel (100 mg/m2 on days 1, 8 and 15 of each 28 day cycle).
Study NCT02788981 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive placebo and nab-paclitaxel (100 mg/m2 on days 1, 8 and 15 of each 28 day cycle).
Study NCT04627207 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-333 1 Tab
Description: Other names: Test
Study NCT02389894 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CardioGard Cannula
Description: CardioGard Cannula, per the manufacturer's instructions for use (IFU).
Study NCT02788981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-Paclitaxel
Description: Patients will either receive placebo and nab-paclitaxel (100 mg/m2 on days 1, 8 and 15 of each 28 day cycle) or patients will receive mifepristone 300 mg daily on the day prior to and day of each dose of nab-paclitaxel (100 mg/m2 on days 1, 8 and 15 of each 28 day cycle). Patients will receive mifepristone and nab-paclitaxel, or placebo and nab-paclitaxel. Not all three.
Study NCT02788981 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nab-Paclitaxel
Description: Patients will either receive placebo and nab-paclitaxel (100 mg/m2 on days 1, 8 and 15 of each 28 day cycle) or patients will receive mifepristone 300 mg daily on the day prior to and day of each dose of nab-paclitaxel (100 mg/m2 on days 1, 8 and 15 of each 28 day cycle). Patients will receive mifepristone and nab-paclitaxel, or placebo and nab-paclitaxel. Not all three.
Study NCT04221646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-899
Description: Treatment with study device.
Study NCT01996280 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Motivational Interviewing
Description: The MI is a single brief motivational intervention lasting 1.5 hrs. The MI includes MI structured strategies tailored to the patient's readiness to change such as: the Typical Day exercise, the use of personal feedback reports (e.g., normative feedback about their drinking), discussions about the pros and cons of use, and completion of a change plan; It is designed to follow MI principles of invoking autonomy and emphasizing collaboration with the interventionist.
Study NCT01996280 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Tailored MI
Description: CTMI is a single brief motivational intervention lasting 1.5hrs. The CTMI follows the same sequence of structured strategies as the MI arm, and while the components in CTMI and MI are parallel, the focus within them is different. CTMI components culturally relevant material, such as acculturation stress. The CTMI components, which are MI structured strategies, are culturally tailored to address relevant concerns and issues. There are also culturally tailored feedback element, such as ethnic normative feedback related to drinking.
Study NCT02424175 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Study NCT03628976 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: tVNS
Description: Intervention
Study NCT03628976 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: tVNS
Description: Intervention
Study NCT03628976 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Motor training
Description: Same finger training for both arms
Study NCT03628976 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motor training
Description: Same finger training for both arms
Study NCT03722394 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education
Description: 15 minute verbal one-on-one education session
Study NCT00748423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitric Oxide
Description: NO in inhalation for 3 days
Study NCT00748423 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo in inhalation for 3 days
Study NCT01047982 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: myo-inositol
Description: myo-inositol 2 grams plus folic acid 400 mcg twice a day
Study NCT01047982 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: folic acid 400 mcg
Description: 2 pills a day
Study NCT03160820 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Measles, mumps and rubella Combined Vaccine, Live
Description: Subjects will be inoculated one dose of MMR vaccine and collected blood samples before and after vaccination.
Study NCT03242811 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI scan of knee, ankle and wrist
Description: At the day of the intervention, the subject is informed about the study by a nurse and provides written informed consent.~Girls must leave urine tests to rule out pregnancy. The questionnaire for the study is answered by the subject and weight and length are measured. The subject is asked to self-assess his/her puberty.~After detailed information on how a magnetic camera examination is carried out, an examination of five selected growth zones (knee joint, ankle joint including heel leg and wrist) is performed using 1.5 Tesla magnetic camera with dedicated cartilage sequence.
Study NCT02806453 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: thickened formula
Study NCT02806453 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mg alginate
Study NCT02311660 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation Device
Description: Cyberonics VNS System
Study NCT02806453 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: reassurance with lifestyle changes
Study NCT01301833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: teneligliptin
Study NCT01301833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: glinide
Study NCT01301833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: biguanide
Study NCT01301833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alpha-glucosidase inhibitor
Study NCT01813448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Description: oral
Study NCT02688881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sirolimus
Description: Rapamune
Study NCT03540628 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Thiamine and Vitamin C
Description: Supplementary vitamins for the patient in septic shock
Study NCT02496715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 100 mcg / salmeterol 50 mcg
Description: Brand inhaler containing pMDI containing fluticasone and salmeterol
Study NCT01813448 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral
Study NCT02373774 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Patients will receive an ultrasound prior to lumbar puncture procedure to help visualize and select spinal interspace.
Study NCT04270539 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nap
Description: Participants will be given 20-min nap opportunity in the classroom on a daily basis during school-days.
Study NCT04301544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: INDAK (Improving Neurocognition through Dance and Kinesthetics)
Description: INDAK (Improving Neurocognition through DAnce and Kinesthetics) is a structured modular dance consisting of 8 types of ballroom dances (Reggae, Cha-cha, Samba, Merengue, Bachata, Swing, Tango and Salsa) with increasing complexity. The intervention group will receive dance intervention from a dance teacher two times a week, one hour each time, for 12 months. Each 60-minute session has 3 parts: 10 minutes warm-up/ stretching, 40 minutes dance proper and 10 minutes cool down. This dance intervention will last for 12 months.
Study NCT04301544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Counseling
Description: The dietary advice will follow Filipino Nutrition Research Institute (FNRI) recommendation called Pinggang Pinoy or Filipino Plate, which is a picture of a nine-inch plate with foods proportionally distributed among the food groups to provide approximately 1,200 to 1,500 calories per day. It is advised that half of the plate is composed of green leafy vegetables and one serving of fruit per meal. For fruits, 4 to 6 servings are encouraged per day. In general, affordable nutritious food is recommended: high consumption of local fruits and vegetables, brown/purple rice instead of white rice, coconut oil and other vegetable oils, and fish. Participants will be asked to use structured 3-day meal diary for diet monitoring. Individual counseling sessions depending on identified vascular risks based on FNRI recommendations will also be conducted. This is followed-up by study nutritionists every 3-month of intervention period.
Study NCT04301544 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition Counseling
Description: The dietary advice will follow Filipino Nutrition Research Institute (FNRI) recommendation called Pinggang Pinoy or Filipino Plate, which is a picture of a nine-inch plate with foods proportionally distributed among the food groups to provide approximately 1,200 to 1,500 calories per day. It is advised that half of the plate is composed of green leafy vegetables and one serving of fruit per meal. For fruits, 4 to 6 servings are encouraged per day. In general, affordable nutritious food is recommended: high consumption of local fruits and vegetables, brown/purple rice instead of white rice, coconut oil and other vegetable oils, and fish. Participants will be asked to use structured 3-day meal diary for diet monitoring. Individual counseling sessions depending on identified vascular risks based on FNRI recommendations will also be conducted. This is followed-up by study nutritionists every 3-month of intervention period.
Study NCT04301544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized Vascular Care
Description: The management advice for hypertension, diabetes, and dyslipidemia will be based on Filipino standard clinical practice guidelines. This is followed-up by study physicians every 3-month of intervention period
Study NCT04301544 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Vascular Care
Description: The management advice for hypertension, diabetes, and dyslipidemia will be based on Filipino standard clinical practice guidelines. This is followed-up by study physicians every 3-month of intervention period
Study NCT00278746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc and ORS
Description: Government and private providers and village health workers were trained to prescribe zinc and ORS for use in diarrheal episodes in 1 month to 5 years old children in intervention communities
Study NCT00278746 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: ORS only
Description: Promoted routine management of diarrhea in underfive with ORS
Study NCT02087969 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry Needling
Study NCT02197390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family wellness workshops
Description: Nine family wellness workshops and eight family physical activity sessions facilitated by community health workers.
Study NCT02197390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Obesity chronic care model
Study NCT02197390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity, healthy eating, water drinking, healthy sleep promotion
Study NCT02197390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Environment, policy, systems changes in clinic setting only
Study NCT02197390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No intervention
Description: No intervention.
Study NCT02197390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Environment, policy, and systems changes in schools, early child care education & recreation
Study NCT04448899 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivabradine Oral Tablet
Description: Ivabradine 5 mg twice daily and doses (2.5, 5, 7.5 mg) were to be adjusted upwards or downwards at every visit according to HR at rest and tolerability plus their standard treatment.
Study NCT04448899 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Blacebo plus standard treatment
Description: Blacebo plus standard treatment
Study NCT02087969 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stretching
Study NCT01588600 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dietary Fiber
Description: Fiber added to breakfast
Study NCT03662438 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Home-based physiotherapy program
Description: The home-based physiotherapy program will consist of a total of 2 home visits by a physiotherapist which will be scheduled at the start and midpoint of the 10-week program. The visit will include activity education, goal setting and establishment of a home exercise regimen in patient's own home and community environment). Participants will be contacted weekly via telephone to provide encouragement for patient on the program, enquire about compliance to the exercise program and safety (e.g. falls and healthcare utilisation).
Study NCT02496715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Generic fluticasone propionate 100 mcg / salmeterol 50 mcg
Description: Generic inhaler containing pMDI containing fluticasone and salmeterol
Study NCT02496715 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo inhaler
Study NCT01266967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2118436
Description: Subjects in this study receive 150 mg of GSK2118436 twice daily and continue on treatment until disease progression, death, or unacceptable adverse event.
Study NCT04346017 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Cytokines dosage
Description: Dosage of inflammatory cytokines and other markers of systemic inflammatory syndromes (TNFa, IFNg, IL1, IL7, IL10, IL12, IL17, sCD25, sCD163, sCD14, IL-6, IL6-R, complex IL6-IL6R, glycolsylated ferritin...).
Study NCT04346017 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cytokines dosage
Description: Dosage of inflammatory cytokines and other markers of systemic inflammatory syndromes (TNFa, IFNg, IL1, IL7, IL10, IL12, IL17, sCD25, sCD163, sCD14, IL-6, IL6-R, complex IL6-IL6R, glycolsylated ferritin...).
Study NCT04346017 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Complement dosage
Description: Dosage of the complement parameters: CH50, C3, C4, C3d, C5a, SC5b-9, C4a, MASP-2.
Study NCT04346017 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Complement dosage
Description: Dosage of the complement parameters: CH50, C3, C4, C3d, C5a, SC5b-9, C4a, MASP-2.
Study NCT02011646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Weight
Description: The PI will train 4 group leaders to deliver the intervention. Groups will be offered four times per week and consist of approximately 10 participants. Each group will be led by 2 group leaders and each group leader will lead two sessions per week during the 2.5 mo intervention period. Group leaders will digitally video-record all sessions of the first two groups they deliver so the PI can provide supervision and rate fidelity and competence for a random selection of 6 of these 12 sessions. Group leaders will transmit the video recordings via an encrypted, secure internet connection to Dr. Ochner (who was trained by Dr. Eric Stice, the creator of the intervention) within 3 d for supervision, and competence and fidelity assessments.
Study NCT02011646 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Controlled Intervention
Description: The Weight of the World is a 51 min documentary focusing on the topics of obesity and healthy living. Via information presented by medical professionals and lifestyle experts, this film delves into issues related to preventing and combating obesity. Major topics include the importance of healthy eating and exercise behaviors and the changes that can be made by communities to reshape our lifestyles. Participants will be given a copy of the DVD. They will also be given the choice to stream it free on the web.
Study NCT01588600 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Fiber
Description: Fiber added to breakfast
Study NCT01063647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treosulfan
Description: 10 g/m² i.v. infusion, day -6, -5, -4
Study NCT01063647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treosulfan
Description: 12 g/m² i.v. infusion, day -6, -5, -4
Study NCT01063647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treosulfan
Description: 14 g/m² i.v. infusion, day -6, -5, -4
Study NCT00554047 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidisciplinary Memory Clinic
Description: Post-diagnosis treatment and coordination of care for patients with dementia and their informal caregivers delivered by Multidisciplinary Memory Clinics (MMCs)
Study NCT00554047 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General Practitioners
Description: Post-diagnosis treatment and coordination of care for patients with dementia and their informal caregivers delivered by general practitioners
Study NCT05675501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encapsulated Benzoyl Peroxide Cream
Description: Subjects will use a pea-size amount for each area of the face
Study NCT05675501 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Encapsulated Benzoyl Peroxide Cream
Description: Subjects will use a pea-size amount for each area of the face
Study NCT04124640 — intervention group
Intervention type: OTHER
Intervention: Patients' data (baseline characteristics, clinical and outcomes) from routine care visits
Description: Use of a standardized scale to collect clinical and patient-centered data, to assess the effectiveness of Libicare in real life in female 45-65 years old. Patients' data (baseline characteristics, clinical and outcomes) will be collected according to sites routine care.